Regeneron
Regeneron's stock sees mixed sentiment as positive news on FDA approvals and innovation is tempered by market performance concerns. Recent social posts highlight potential buyouts and CEO compensation, alongside advancements in genetic medicine and drug development.
About Regeneron
Regeneron Pharmaceuticals is a biotechnology company focused on the discovery, development, and commercialization of medicines.
Insights
- regeneron sentiment is up 16.28% from the previous week.
- regeneron engagements is up 27.72% from the previous week.
Engagements: [------] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [------]
[--] Week: [-------] +28%
[--] Month: [-------] -95%
[--] Months: [----------] +168%
[--] Year: [----------] +285%
1-Year High: [----------] on 2026-01-05
1-Year Low: [--] on 2025-09-07
Engagements by network (24h): X: [-----] Instagram: [------] YouTube: [------] News: [--] Reddit: [---] TikTok: [-----]
Mentions: [---] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] +2%
[--] Month: [-----] +4.80%
[--] Months: [-----] +40%
[--] Year: [-----] +113%
1-Year High: [---] on 2025-12-22
1-Year Low: [--] on 2025-09-07
Mentions by network (24h): X: [--] Instagram: [--] YouTube: [---] News: [--] Reddit: [--] TikTok: [--]
Creators: [---] (24h)
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning Regeneron in the last [--] hours which is up 8.30% from [---] in the previous [--] hours
Daily Average: [---]
[--] Week: [---] -1.50%
[--] Month: [---] +11%
[--] Months: [-----] +22%
[--] Year: [-----] +129%
1-Year High: [---] on 2025-05-20
1-Year Low: [--] on 2025-09-07
The most influential creators that mention Regeneron in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @tunemusicalmoments | [--] | [---------] | [--] | [------] |
| @regeneron | [--] | [--] | [------] | |
| @drsiyabmd | [--] | [-------] | [--] | [-----] |
| @nataninvesting | [--] | [------] | [--] | [---] |
| @laurenpcrna | [--] | [-------] | [--] | [---] |
| @grok | [--] | [---------] | [--] | [---] |
| @okie_kim4.0 | [--] | [------] | [--] | [--] |
| @justinskycak | [--] | [------] | [--] | [--] |
| @TodoDermatitis | [--] | [-----] | [--] | [--] |
| @tomonota | [--] | [------] | [--] | [--] |
Sentiment: 89%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 89%
Daily Average: 87%
[--] Week: 100% +14%
[--] Month: 77% -11%
[--] Months: 77% -14%
[--] Year: 77% -17%
1-Year High: 100% on 2025-02-21
1-Year Low: 22% on 2025-06-14
Most Supportive Themes:
- Positive News and Partnerships: (40%) Regeneron's recent FDA approvals for Eylea HD and the expansion of Libtayo in the EU are driving positive sentiment, alongside news of significant investment and job creation in New York.
- Innovation and Research: (20%) Mentions of Regeneron's scientific breakthroughs, such as the development of a cost-effective prosthetic arm by a Regeneron Science Talent Search finalist and advancements in genetic medicine, are generating interest.
Most Critical Themes:
- Market Performance Concerns: (25%) Some discussions touch upon Regeneron's stock fluctuations and past underperformance, though recent news of FDA approvals and investment may be counteracting this.
- Negative Sentiment and Criticism: (15%) A smaller portion of posts express negative sentiment, including criticism of the company or its products, though this appears to be outweighed by positive news.
Top Regeneron Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"As of Feb [--] [----] no confirmed news or announcements indicate a $NTLA buyout. Recent developments focus on clinical progress and insider buying suggesting independent growth. Probability is low (around 10-15%) but speculative. Potential buyers might include Regeneron (existing partner) Novartis or Vertex. https://twitter.com/i/web/status/2023495969560494350 https://twitter.com/i/web/status/2023495969560494350"
X Link @grok 2026-02-16T20:33Z 8M followers, [---] engagements
"Dragonfly Capital - [--] Trade Ideas for Tuesday: Crowdstrike Murphy USA Netscout Regeneron and Scotts Miracle-Gro $CRWD $MUSA $NTCT $REGN $SMG https://dragonflycap.com/5-trade-ideas-for-tuesday-crowdstrike-murphy-usa-netscout-regeneron-and-scotts-miracle-gro/ https://dragonflycap.com/5-trade-ideas-for-tuesday-crowdstrike-murphy-usa-netscout-regeneron-and-scotts-miracle-gro/"
X Link @harmongreg 2026-02-16T17:43Z 51.2K followers, [---] engagements
"💰 Highest Paid CEOs in the World 💰 [--]. Elon Musk Tesla $23.5 billion [--]. Tim Cook Apple $770.5 million [--]. Jensen Huang NVIDIA $561 million [--]. Reed Hastings Netflix $453.5 million [--]. Leonard Schleifer Regeneron $452.9 million [--]. Marc Benioff Salesforce $439.4 million [--]. Satya Nadella Microsoft $309.4 million [--]. Robert A. Kotick Activision Blizzard $296.7 million [--]. Hock E. Tan Broadcom $288 million [--]. Sundar Pichai Google (Alphabet) $280 million [--]. Andy Jassy Amazon $245 million [--]. Jamie Dimon JPMorgan Chase $230 million [--]. Nikesh Arora Palo Alto Networks $200$150 million [--]. Shantanu"
X Link @Stat_Cult 2026-02-16T03:47Z 31.3K followers, 13.3K engagements
"Natan YTD: -6.7% S&P500 YTD: -0.1% TOTAL RETURNS (Jan 2022) Natan's portfolio: +108.2% *Benchmark: +36.3% S&P500: +51.8% MY POSITIONS: 18.6% Transmedics $TMDX 15.3% Pinduoduo $PDD 9.1% Alibaba $BABA 7.6% Regeneron $REGN 7.4% Procept BioRobotics $PRCT 7.0% Meta Platforms $META 6.3% Paypal $PYPL 6.3% Robinhood $HOOD 5.7% Wizz Air $WIZZ 5.1% B2gold $BTG 5.0% Moderna $MRNA 3.5% Monday $MNDY 1.8% Edwards Lifesciences $EW 1.3% Crispr Therapeutics $CRSP Follow me: @nataninvesting - - - - - - - - - - - - - - - - - - - * : - 70% - 30% ** . ' and all the ."
X Link @nataninvesting 2026-02-14T13:49Z 39.5K followers, 12.6K engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing